C-reactive protein concentration distribution among US children and young adults: Findings from the National Health and Nutrition Examination Survey, 1999-2000

Clinical Chemistry

Volumn 49, Issue 8, 2003, Pages 1353-1357

  Ford, Earl S ^a,e   Giles, Wayne H ^a   Myers, Gary L ^b   Rifai, Nader ^c   Ridker, Paul M ^d   Mannino, David M ^b  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHILD NUTRITION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ETHNIC DIFFERENCE; FEMALE; GEOMETRY; GROUPS BY AGE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL STATUS; PROTEIN DETERMINATION; RACE DIFFERENCE; TURBIDIMETRY; VALIDATION PROCESS;

ADOLESCENT; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; C-REACTIVE PROTEIN; CHILD; CHILD, PRESCHOOL; DATA COLLECTION; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MALE; MEXICAN AMERICANS; MIDDLE AGED; NEPHELOMETRY AND TURBIDIMETRY; REFERENCE VALUES;

EID: 0042868820     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/49.8.1353     Document Type: Article

References (23)

1. Du Clos TW. Function of C-reactive protein. Ann Med 2000;32:274-8.
2. Ridker PM. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 2001;103:1813-8.
3. Velican C, Velican D. Coronary arteries in children up to the age of ten years. II. Intimal thickening and its role in atherosclerotic involvement. Med interne 1976;14:17-24.
4. Lesauskaite V, Tanganelli P, Bianciardi G, Simoes C, Toti P, Weber G. World Health Organization (WHO) and the World Heart Federation (WHF) Pathobiological Determinants of Atherosclerosis in Youth (PBDAY) Study. Histomorphometric investigation of the aorta and coronary arteries in young people from different geographical locations. Nutr Metab Cardiovasc Dis 1999;9:266-76.
5. McGill HC Jr, McMahan CA, Zieske AW, Sloop GD, Walcott JV, Troxclair DA, et al. Associations of coronary heart disease risk factors with the intermediate lesion of atherosclerosis in youth. The Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Arterioscler Thromb Vasc Biol 2000;20:1998-2004.
6. Millonig G, Malcom GT, Wick G. Early inflammatory-immunological lesions in juvenile atherosclerosis from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY)-study. Atherosclerosis 2002;160:441-8.
7. Nicklas TA, von Duvillard SP, Berenson GS. Tracking of serum lipids and lipoproteins from childhood to dyslipidemia in adults: the Bogalusa Heart Study. Int J Sports Med 2002;23(Suppl1):S39-43.
8. Janz KF, Dawson JD, Mahoney LT. Tracking physical fitness and physical activity from childhood to adolescence: the Muscatine Study. Med Sci Sports Exerc 2000;32:1250-7.
9. Raitakari OT, Porkka KV, Rasanen L, Ronnemaa T, Viikari JS. Clustering and six year cluster-tracking of serum total cholesterol, HDL-cholesterol and diastolic blood pressure in children and young adults. The Cardiovascular Risk in Young Finns Study. J Clin Epidemiol 1994;47:1085-93.
10. Cook DG, Mendall MA, Whincup PH, Carey IM, Ballam L, Morris JE, et al. C-reactive protein concentration in children: relationship to adiposity and other cardiovascular risk factors. Atherosclerosis 2000;149:139-50.
11. Ford ES, Galuska DA, Gillespie C, Will JC, Giles WH, Dietz WH. C-reactive protein and body mass index in children: findings from the Third National Health and Nutrition Examination Survey, 1988-1994. J Pediatr 2001;138:486-92.
12. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Low-grade systemic inflammation in overweight children. Pediatrics 2001;107:E13.
13. Ford ES, Gillespie C, Ballew C, Sowell A, Mannino DM. Serum carotenoid concentrations among US children. Am J Clin Nut 2002;76:818-27.
14. Centers for Disease Control and Prevention. NHANES 1999-2000 public data release file documentation. Hyattsville, MD: National Center for Health Statistics. http://www.cdc.gov/nchs/about/major/nhanes/currentnhanes.htm (Accessed March 4, 2003).
15. Ledue TB, Weiner DL, Sipe JD, Poulin SE, Collins MF, Rifai N. Analytical evaluation of particle-enhanced immunonephelometric assays for C-reactive protein, serum amyloid A and mannose-binding protein in human serum. Ann Clin Biochem 1998;35:745-53.
16. Research Triangle Institute. SUDAAN user's manual, Release 8.0. Research Triangle Park, NC: Research Triangle Institute, 2001.
17. Zilow G, Zilow EP, Burger R, Linderkamp O. Complement activation in newborn infants with early onset infection. Pediatr Res 1993;34:199-203.
18. Jarvisalo MJ, Harmoinen A, Hakanen M, Paakkunainen U, Viikari J, Hartiala J, et al. Elevated serum C-reactive protein levels and early arterial changes in healthy children. Arterioscler Thromb Vasc Biol 2002;22:1323-8.
19. Kluft C, de Maat MP. Determination of the habitual low blood level of C-reactive protein in individuals. Ital Heart J 2001;2:172-80.
20. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003;107:499-511.
21. Roberts WL, Sedrick R, Moulton L, Spencer A, Rifai N. Evaluation of four automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Clin chem 2000;46:461-8.
22. Roberts WL, Moulton L, Law TC, Farrow G, Cooper-Anderson M, Savory J, et al. Evaluation of nine automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Part 2. Clin Chem 2001;47:418-25.
23. Rifai N, Ridker PM. Proposed cardiovascular risk assessment algorithm using high-sensitivity C-reactive protein and lipid screening. Clin Chem 2001;47:28-30.